外染色体圆形DNA (eccDNA):从致癌性到耐药性
1Department of Hepatobiliary Surgery, Yijishan Hospital of Wannan Medical College, Wuhu, China.
Clinical and experimental medicine
|April 25, 2024
概括
染色体外圆形DNA (eccDNA) 在各种癌症中起着关键作用. 研究突出了eccDNA的研究成果.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 染色体外圆形DNA (eccDNA) 存在于主要染色体之外.
- 最近的研究将eccDNA与各种癌症类型联系起来,包括乳腺癌,肺癌和卵巢癌.
- 科学界对eccDNA的研究已经得到了很大的关注.
研究的目的:
- 审查eccDNA的起源,分类和生物发生机制.
- 探索eccDNA与各种癌症之间的关联.
- 总结eccDNA在癌症发展和进展中的作用,并讨论未来的应用.
主要方法:
- 对eccDNA现有研究的文献综述.
- 对eccDNA生物发生路径的分析.
- 关于eccDNA参与瘤发生的综合数据.
主要成果:
- eccDNA与多种瘤的产生和演变有关.
- 了解eccDNA的作用可以了解癌症机制.
- 该审查涵盖了eccDNA来源,分类和生物发生.
结论:
- 在癌症研究中,eccDNA很重要,它会影响瘤的发展.
- 对eccDNA的进一步研究为新的癌症检测和治疗策略提供了潜力.
- 本综述巩固了目前的知识和eccDNA在瘤学研究的未来方向.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


